The November 25 incident involved a resident with chronic respiratory failure and low blood oxygen levels who required twice-daily breathing treatments with Budesonide, a medication for chronic obstructive pulmonary disease. Federal inspectors found that Licensed Vocational Nurse 2 administered the 8:00 a.m. treatment but failed to follow basic safety protocols.
The facility's Director of Nursing told inspectors the licensed nurse should have remained with the resident throughout the entire treatment, monitoring for difficulty breathing, anxiety, or distress. More critically, the nurse should have removed the nebulizer face mask once the medication was completed.
"This practice was required to ensure resident safety during breathing treatments," the Director of Nursing stated during the inspection interview.
The resident had been admitted to Community Care on Palm with a diagnosis of chronic respiratory failure with hypoxia. A physician's order from April 4, 2025, specified the Budesonide inhalation suspension should be administered at 0.5 milligrams per 2 milliliters, inhaled twice daily to treat the chronic obstructive pulmonary disease with exacerbation.
The facility's own policy, titled "Administering Medications Through a Small Volume Nebulizer" and dated October 2010, explicitly outlined the safety requirements the nurse ignored. The policy's stated purpose was "to safely and aseptically administer aerosolized particles of medication into the resident's airway."
Those written procedures required nurses to remain with residents throughout treatments and monitor for medication side effects including rapid pulse, restlessness and nervousness. The policy also mandated that nurses obtain post-treatment vital signs, including pulse, respiratory rate and lung sounds.
The protocol detailed specific steps: assemble the nebulizer equipment, instruct the resident on proper breathing patterns, encourage deep breaths followed by normal exhalation, and continue until the medication was completely nebulized or the designated treatment time was reached.
"Remain with the resident for the treatment," the policy stated clearly.
The policy also required nurses to encourage residents to cough and expectorate as needed during the treatment, then turn off the nebulizer and disconnect all equipment when the therapy was complete.
For residents with chronic respiratory conditions like this patient, nebulizer treatments deliver medication directly to the lungs through aerosolized particles. The treatments require careful monitoring because patients can experience adverse reactions including changes in heart rate, breathing patterns, or anxiety levels.
Leaving a resident unattended during such treatments violates fundamental nursing care standards, particularly for patients already struggling with compromised breathing. The failure to remove the face mask after treatment completion compounds the safety risk.
The electronic Medication Administration Record showed LVN 2 documented administering the Budesonide at 8:00 a.m. on November 25, but the inspection revealed the nurse's failure to complete the treatment safely.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm, affecting few residents. However, the incident highlights gaps in medication administration oversight at the facility.
The resident's underlying condition made proper monitoring especially critical. Chronic obstructive pulmonary disease with exacerbation represents a serious respiratory condition where patients experience flare-ups that worsen their already compromised breathing ability.
During these episodes, patients rely on nebulizer treatments to deliver bronchodilators and anti-inflammatory medications directly to their airways. The treatments can provide significant relief, but they require skilled nursing supervision to ensure safety and effectiveness.
The facility's policy recognized these risks by requiring continuous monitoring for side effects and post-treatment assessments of vital signs and lung sounds. These protocols exist specifically to catch complications before they become dangerous.
By walking away from the treatment, LVN 2 left the resident vulnerable to potential respiratory distress without anyone present to intervene. The failure to remove the face mask after completion meant the resident remained connected to equipment that should have been disconnected and cleaned.
The inspection found that basic nursing protocols established more than a decade earlier were simply ignored during this critical medication administration. The Director of Nursing's acknowledgment that the nurse should have stayed and monitored the resident confirmed the facility understood its own safety requirements.
For a resident already struggling with chronic respiratory failure and low oxygen levels, this abandonment of care standards represented a fundamental breach of nursing responsibility.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Community Care On Palm from 2025-11-25 including all violations, facility responses, and corrective action plans.